Simran Maggo

506 total citations
32 papers, 317 citations indexed

About

Simran Maggo is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Simran Maggo has authored 32 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Simran Maggo's work include Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical studies and practices (5 papers) and Genomics and Rare Diseases (3 papers). Simran Maggo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Pharmaceutical studies and practices (5 papers) and Genomics and Rare Diseases (3 papers). Simran Maggo collaborates with scholars based in New Zealand, United States and Malaysia. Simran Maggo's co-authors include Martin A. Kennedy, David W. J. Clark, John C. Ashton, Paul K. L. Chin, Allison L. Miller, Ruth Savage, Simone L. Cree, John F. Pearson, Janelle Ashton and Jack Rivers‐Auty and has published in prestigious journals such as The Journal of Pediatrics, European Journal of Pharmacology and Neuroreport.

In The Last Decade

Simran Maggo

25 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simran Maggo New Zealand	11	114	101	76	59	44	32	317
Tong Lin China	12	31 0.3×	159 1.6×	40 0.5×	32 0.5×	48 1.1×	45	461
Rick D. Fannin United States	8	58 0.5×	166 1.6×	23 0.3×	49 0.8×	45 1.0×	14	392
Xue Gao China	12	42 0.4×	141 1.4×	90 1.2×	23 0.4×	32 0.7×	31	430
Zhuoshan Huang China	9	109 1.0×	113 1.1×	21 0.3×	15 0.3×	47 1.1×	31	395
Peter Arnold Switzerland	8	78 0.7×	158 1.6×	97 1.3×	53 0.9×	14 0.3×	9	433
H.J. Lim South Korea	6	35 0.3×	128 1.3×	98 1.3×	93 1.6×	24 0.5×	11	453
Kaori Morimoto Japan	8	48 0.4×	113 1.1×	64 0.8×	41 0.7×	123 2.8×	14	383
Jie Yin Yee Singapore	12	74 0.6×	163 1.6×	25 0.3×	23 0.4×	85 1.9×	33	384
Pei-Chieng Cha Japan	7	111 1.0×	66 0.7×	12 0.2×	27 0.5×	57 1.3×	11	225
Muir Russell United Kingdom	8	58 0.5×	76 0.8×	14 0.2×	96 1.6×	56 1.3×	10	342

Countries citing papers authored by Simran Maggo

Since Specialization

Citations

This map shows the geographic impact of Simran Maggo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simran Maggo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simran Maggo more than expected).

Fields of papers citing papers by Simran Maggo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simran Maggo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simran Maggo. The network helps show where Simran Maggo may publish in the future.

Co-authorship network of co-authors of Simran Maggo

This figure shows the co-authorship network connecting the top 25 collaborators of Simran Maggo. A scholar is included among the top collaborators of Simran Maggo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simran Maggo. Simran Maggo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hahn, Elan, Avinash V. Dharmadhikari, Simran Maggo, et al.. (2025). Copy number variant analysis improves diagnostic yield in a diverse pediatric exome sequencing cohort. npj Genomic Medicine. 10(1). 16–16.

Chua, Eng Wee, et al.. (2025). Nanopore sequencing-based genotyping suggested an association between CYP2D6 function and susceptibility to anxiety and depression. BMC Research Notes. 18(1). 88–88.

Maggo, Simran, et al.. (2025). Opioid-Related Pharmacogenomic Variants in a Retrospective Cohort of High-Risk Hospitalized Infants. The Journal of Pediatrics. 287. 114725–114725.

Momcilovic, Milica, Dejerianne Ostrow, Simran Maggo, et al.. (2024). Trafficking of mitochondrial double-stranded RNA from mitochondria to the cytosol. Life Science Alliance. 7(9). e202302396–e202302396. 5 indexed citations

Maggo, Simran, et al.. (2023). The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses. Frontiers in Pharmacology. 14. 1080117–1080117. 9 indexed citations

Maggo, Simran, et al.. (2023). Long-Range Polymerase Chain Reaction. Methods in molecular biology. 2967. 181–192. 4 indexed citations

Merriman, Tony R., Allison L. Miller, John F. Pearson, et al.. (2022). Allelic diversity of the pharmacogene CYP2D6 in New Zealand Māori and Pacific peoples. Frontiers in Genetics. 13. 1016416–1016416. 5 indexed citations

Maggo, Simran, et al.. (2019). Nanopore Sequencing of the Pharmacogene CYP2D6 Allows Simultaneous Haplotyping and Detection of Duplications. Pharmacogenomics. 20(14). 1033–1047. 34 indexed citations

Searchfield, Grant D., Mithila Durai, Martin A. Kennedy, et al.. (2019). A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity. International Journal of Neuroscience. 130(7). 671–682. 6 indexed citations

10.

Maggo, Simran, Martin A. Kennedy, Allison L. Miller, et al.. (2019). Common CYP2D6, CYP2C9, and CYP2C19 Gene Variants, Health Anxiety, and Neuroticism Are Not Associated With Self-Reported Antidepressant Side Effects. Frontiers in Genetics. 10. 1199–1199. 10 indexed citations

11.

Maggo, Simran, et al.. (2019). The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand. Frontiers in Psychiatry. 10. 690–690. 12 indexed citations

12.

Maggo, Simran, Eng Wee Chua, Paul K. L. Chin, et al.. (2017). A New Zealand platform to enable genetic investigation of adverse drug reactions.. PubMed. 130(1466). 62–69. 8 indexed citations

13.

Bolaji, Oluseye O., et al.. (2017). Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population. Drug Metabolism and Personalized Therapy. 32(1). 39–47. 6 indexed citations

14.

Chua, Eng Wee, Simran Maggo, & Martin A. Kennedy. (2017). Long Fragment Polymerase Chain Reaction. Methods in molecular biology. 1620. 65–74. 5 indexed citations

15.

Maggo, Simran, Ruth Savage, & Martin A. Kennedy. (2015). Impact of New Genomic Technologies on Understanding Adverse Drug Reactions. Clinical Pharmacokinetics. 55(4). 419–436. 15 indexed citations

16.

Maggo, Simran & John C. Ashton. (2013). Effects of HMG-CoA reductase inhibitors on learning and memory in the guinea pig. European Journal of Pharmacology. 723. 294–304. 14 indexed citations

17.

Harrison‐Woolrych, Mira, Linda Härmark, Ming Tan, Simran Maggo, & Kees van Grootheest. (2012). Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres. European Journal of Clinical Pharmacology. 68(7). 1065–1072.

18.

Rivers‐Auty, Jack, Simran Maggo, & John C. Ashton. (2011). Neuroprotective effect of hydroxypropyl-β-cyclodextrin in hypoxia-ischemia. Neuroreport. 23(3). 134–138. 15 indexed citations

19.

Harrison‐Woolrych, Mira, Simran Maggo, Ming Tan, Ruth Savage, & Janelle Ashton. (2011). Cardiovascular Events in Patients taking Varenicline. Drug Safety. 35(1). 33–43. 24 indexed citations

20.

Maggo, Simran, Martin A. Kennedy, & David W. J. Clark. (2010). Clinical Implications of Pharmacogenetic Variation on the Effects of Statins. Drug Safety. 34(1). 1–19. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact